ALZHEIMERS DISEASE RESEARCH FOUNDATION: Form 990, tax year 2011
View the entire original 990 at ProPublica ↗
- Organization
- ALZHEIMERS DISEASE RESEARCH FOUNDATION (EIN 52-2396428)
- Tax period
- 2011-01-01 to 2011-12-31
- Filed
- 2012-05-04
- IRS object ID
- 201211259349301506
- Schema version
- 2011v1.2
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule I
- Schedule J
- Schedule M
- Schedule O
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Timestamp | 2012-05-04T16:14:13-05:00 | Timestamp |
| Tax Period End Date | 2011-12-31 | TaxPeriodEndDate |
Preparer Firm PreparerFirm
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 042824790 | EIN |
Preparer Firm Business Name PreparerFirmBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | John A Epeneter PC | BusinessNameLine1 |
Preparer Firm US Address PreparerFirmUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1 Marginal Way | AddressLine1 |
| City | Springvale | City |
| State | ME | State |
| ZIP Code | 04083 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnType |
| Tax Period Begin Date | 2011-01-01 | TaxPeriodBeginDate |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 522396428 | EIN |
Name Name
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Alzheimer's Disease Research Foundation | BusinessNameLine1 |
| Business Name Line2 | Cure Alzheimer's Fund | BusinessNameLine2 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Control | ALZH | NameControl |
| Phone | 7812373800 | Phone |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 34 Washington Street No 200 | AddressLine1 |
| City | Wellesley | City |
| State | MA | State |
| ZIP Code | 02481 | ZIPCode |
Officer Officer
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name | timothy w armour | Name |
| Title | President | Title |
| Phone | 8772873259 | Phone |
| Date Signed | 2012-05-04 | DateSigned |
| Authorize Third Party | 1 | AuthorizeThirdParty |
Preparer Preparer
| Field | Value | IRS element (for citing) |
|---|---|---|
| PTIN | P00637532 | PTIN |
| Phone | 2074597803 | Phone |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax Year | 2011 | TaxYear |
| Build TS | 2016-02-24 21:20:13Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Of Principal Officer Person | Timothy W Armour | NameOfPrincipalOfficerPerson |
Address Principal Officer US AddressPrincipalOfficerUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 21 Sunset Road | AddressLine1 |
| City | Weston | City |
| State | MA | State |
| ZIP Code | 02493 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | 4687274 | GrossReceipts |
| Group Return For Affiliates | 0 | GroupReturnForAffiliates |
| Organization501c3 | X | Organization501c3 |
| Web Site | www.curealzfund.org | WebSite |
| Type Of Organization Corporation | X | TypeOfOrganizationCorporation |
| Year Formation | 2004 | YearFormation |
| State Legal Domicile | PA | StateLegalDomicile |
| Activity Or Mission Description | To fund research with the highest probability of preventing, slowing or reversing Alzheimer's disease. | ActivityOrMissionDescription |
| Nbr Voting Members Governing Body | 6 | NbrVotingMembersGoverningBody |
| Nbr Independent Voting Members | 5 | NbrIndependentVotingMembers |
| Total Nbr Employees | 6 | TotalNbrEmployees |
| Total Nbr Volunteers | 6 | TotalNbrVolunteers |
| Total Gross UBI | 0 | TotalGrossUBI |
| Net Unrelated Business Txbl Income | 0 | NetUnrelatedBusinessTxblIncome |
| Contributions Grants Prior Year | 3983161 | ContributionsGrantsPriorYear |
| Contributions Grants Current Year | 4682190 | ContributionsGrantsCurrentYear |
| Program Service Revenue Prior Year | 0 | ProgramServiceRevenuePriorYear |
| Program Service Revenue CY | 0 | ProgramServiceRevenueCY |
| Investment Income Prior Year | -5755 | InvestmentIncomePriorYear |
| Investment Income Current Year | 5084 | InvestmentIncomeCurrentYear |
| Other Revenue Prior Year | 0 | OtherRevenuePriorYear |
| Other Revenue Current Year | 0 | OtherRevenueCurrentYear |
| Total Revenue Prior Year | 3977406 | TotalRevenuePriorYear |
| Total Revenue Current Year | 4687274 | TotalRevenueCurrentYear |
| Grants And Similar Amnts Prior Year | 3394263 | GrantsAndSimilarAmntsPriorYear |
| Grants And Similar Amnts CY | 2052500 | GrantsAndSimilarAmntsCY |
| Benefits Paid To Members Prior Year | 0 | BenefitsPaidToMembersPriorYear |
| Benefits Paid To Members CY | 0 | BenefitsPaidToMembersCY |
| Salaries Etc Prior Year | 305410 | SalariesEtcPriorYear |
| Salaries Etc Current Year | 445931 | SalariesEtcCurrentYear |
| Total Prof Fundrsng Exp Prior Year | 0 | TotalProfFundrsngExpPriorYear |
| Total Prof Fundrsng Exp CY | 0 | TotalProfFundrsngExpCY |
| Total Fundrsng Exp Current Year | 267051 | TotalFundrsngExpCurrentYear |
| Other Expense Prior Year | 382718 | OtherExpensePriorYear |
| Other Expenses Current Year | 624839 | OtherExpensesCurrentYear |
| Total Expenses Prior Year | 4082391 | TotalExpensesPriorYear |
| Total Expenses Current Year | 3123270 | TotalExpensesCurrentYear |
| Revenues Less Expenses Prior Year | -104985 | RevenuesLessExpensesPriorYear |
| Revenues Less Expenses CY | 1564004 | RevenuesLessExpensesCY |
| Total Assets BOY | 3273139 | TotalAssetsBOY |
| Total Assets EOY | 4601371 | TotalAssetsEOY |
| Total Liabilities BOY | 318936 | TotalLiabilitiesBOY |
| Total Liabilities EOY | 50903 | TotalLiabilitiesEOY |
| Net Assets Or Fund Balances BOY | 2954203 | NetAssetsOrFundBalancesBOY |
| Net Assets Or Fund Balances EOY | 4550468 | NetAssetsOrFundBalancesEOY |
| Info In Schedule O Part III | X | InfoInScheduleOPartIII |
| Mission Description | To fund research with the highest probability of preventing, slowing or reversing Alzheimer's disease. | MissionDescription |
| Significant New Program Services | 0 | SignificantNewProgramServices |
| Significant Change | 0 | SignificantChange |
| Expense | 600000 | Expense |
| Description | See Schedule O for description.The Alzheimer's Genome Project (AGP) has been Cure Alzheimer's Fund signature research effort for several years. The objective is to identify all genes confirming risk for or protection against Alzheimer's disease.In 2011 Cure Alzheimer's Fund distributed $2,117,823 for research support projects. To read a more detailed report on our research, see Cure Alzheimer Fund's Scientific Report 2011.AGP; Massachusetts General Hospital; Dr. Rudy Tanzi;Since starting the project, over 120 Alzheimer's gene candidates have been identified. The AGP now continues with the objective of a) confirming which of those candidate genes are actual Alzheimer's genes, and b) understanding how they affect Alzheimer's pathology. | Description |
Activity2 Activity2
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 100000 | Expense |
| Description | Molecular Tweezers: Novel Inhibitors of amyloidogenic porteins and promising drug candidates for Alzheimer's disease; Gal Bitan; University of California, Los Angeles.We propose a focused program that will allow us to plan expanded in vivo characterization of the efficacy of novel compounds called "molecular tweezers,"which modulate the aberrant assembly process using a heretofore-unexplored "process-specific" mechanism towards development of disease-modifying therapy for AD and related diseases. | Description |
Activity3 Activity3
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 408104 | Expense |
| Description | Program service costs, such as an allocated portion of program salaries, fringe benefits, information and awareness, SAB/RC support, and similar direct program costs that have not been specifically allocated to the amounts of specific grant expenditures. | Description |
Activity Other ActivityOther (15 entries)
| ExpenseExpense | DescriptionDescription |
|---|---|
| 100000 | Modulation of Abeta Deposition by Cell-Specific Mechanisms; University of Chicago; Dr. Sangram Sisodia.The specific aims of this proposal are to employ genetic and molecular strategies to conditionally delete Familial Alzheimer's disease (FAD)-linked mutant transgenes in specific cell types of the Central Nervous System in order to explore the effects of this manipulation on Abeta deposition. |
| 150000 | Novel Soluable Gamma-Secretase Modulators; Steven Wagner; University of California, San Diego.Many investigators have explored Gamma-secretase modulators (GSMs) as ways of affecting Abeta production and therefore interrupting the earliest stages of Alzheimer's pathology. One reason for the lack of success in this area has been that earlier GSMs were insoluble. We propose to synthesize a photoaffinity probe based on the most potent Soluble Gamma-Secretase Modulator compound that we have developed which will be used in photolabeling and affinity capture experiments in order to provide direct evidence for the molecular target of these AGSMs. These photoaffinity-labeling and affinity capture studies using the SGSM photoprobe will be carried out in collaboration with Dr.Rudy Tanzi using various reconstituted and well charcterized y-secretase assay systems as described previously. |
| 100000 | Effect of Bexaratene on Abeta in Alzheimer's disease; Washington University, St. Louis; David Holtzman.We will assess the efects of bexarotene, a drug originally developed to treat a rare type of lymhoma, on interstitialfluid AB levels over hours as well as its effects on behavior and AB deposition and associated pathology over weeks and months. This will confirm and extend results from the laboratory of Gary Landreth at Case Western Reserve University whose work on bexarotene suggests it may be particularly effective as a treatment for Alzheimer's disease. |
| 150000 | Optimization of Novel ACAT Inhibitors for Alzheimer's Disease; Dora M. Kovacs; Massachusetts General Hospital.We have recently designed and screened a library of 45 novel ACAT inhibitors, based on the structure of CI-1011. From this screen, we have identified three novel ACAT inhibitors that reduce AB generation. Here we will optimize these three inhibitors by screening a novel library of compounds based on their structure. We will determine whether the novel inhibitors prevent development of amyloid pathology and alter APP process in AD mice in absence of toxicity. These studies should result in one or more novel ACAT inhibitors with the potential to prevent and treat AD. |
| 100000 | Structural and Functional Analysis of Novel Abeta and Tau Oligomers Using Conformation-specific Monoclonal Antibodies; George S. Bloom, Ph.D.; University of Virginia, Charlottesville, Virginia.The specific goals of this project are to determine if any of the antibodies developed in the laboratory of Charles Glabe, UC-Irvine, recognize the beta-amyloid or tau oligomers that the Bloom lab is studying, and whether the antibodies can prevent formation of those oligomers. Completion of this work could lead eventually to new diagnostic and therapeutic tools for AD. |
| 100000 | Cellular and Animal Models of Amyloid Pathology in Early Alzheimer's Disease; Charles Glabe, Ph.D.;University of California, Irvine, California.The significance of this work is the identification of the earliest type of amyloid pathology in the beginning of the disease and the discovery of a novel mechanism for amyloid pathogenesis. This may provide a new target for therapeutic development and provide evidence for the early. |
| 100000 | Exploring Adult Neurogenesis as a Therapeutic Target for Alzheimer's Disease; Se Hoon Choi, Ph.D.; Massachusetts General Hospital, Boston, Massachusetts.Recent evidence shows that the adult brain contains discrete populations of stem cells that retain the capacity to generate new neurons through the process of neurogenesis. We will test whether the strategy of stimulation of endogenous stem cells in the AD brain is safe and effective ultimately to find treatment for Alzheimer's patients. |
| 100000 | Alzheimer's Disease Models Based on Human Neuronal Progenitor Cells; Doo Yeon Kim, Ph.D.; Massachusetts General Hospital, Boston, Massachusetts.We propose to develop Alzheimer disease models based on human neural progenitor cells. Human neural progenitor cells are multipotent stem cells that can differentiate to brain cells in in vitro and in vivo conditions. In this study, we will develop genetically modified human neural progenitor cells that can replicate Alzheimer's disease pathology in in vitro and in vivo conditions. Our study will provide a novel Alzheimer's disease model system that can be used to develop and test Alzhemier's disease drugs in human brain cells. Our study will also provide a human Alzheimer's disease model for basic researches. |
| 100000 | Role of ADAM10 in the Pathogenesis of Alzheimer's Disease After Head Trauma; Dr. Giuseppina Tesco; Tufts University School of Medicine, Boston, Massachusetts.Traumatic brain injury (TBI) is the strongest environmental risk factor for the development of Alzheimer's Disease (AD). In addition, cleavage of the APP protein by a-secretase gives rise to the production of the secreted alph cleaved APP fragment (sAPPa), which has been shown to have neuroprotective properties. A recent study has shown that when synthetic sAPPa is administered to mice following experimental head trauma it appears to be protective, reducing neuronal death and axonal injury. If the neuroprotective properties of sAPPa following head trauma can be confirmed, this provides a potential therapeutic strategy for improving a patient's clinical outcome and reducing the potential for the development of AD following head trauma. |
| 100000 | Metallomic Mapping of the Aging Brain in the Trg2576 Mouse model; Dr. Lee Goldstein; Boston University, Boston, Massachusetts.Zinc and other key brain biometals play a critical role in normal brain function, and when altered, development of Alzheimer's disease. Recent clinical trials strongly support development of drugs targeting brain biometals and metal-protein interactions as a promising therapeutic stragegy for this devastating neurodegenerative disease. In this project, Dr. Goldstein will deploy unique analytical resources at the Boston University center for Biometals & Metallomics to perform the first high-resolution metallomic brain maps of key biometals (copper, zinc, iron) during normal brain aging and Alzheimer's disease. |
| 100000 | Selective Cell Vulnerability in Alzheimer's Disease; Dr. Paul Greengard; The Rockefeller University, New York City, New York.The Greengard Laboratory recently developed a new procedure to compare the molecular profiles of very specific cell types inside the brain. They will apply this technology in order to compare vulnerable regions with more resistant regions that don't show any pathology until late stages of the disease. |
| 50000 | Understanding the up-regulation of Neurosperpin in Alzheimer's disease brain and isolating a potential therapeutic inhibitor of its action; a continuation. Dr. Nicholas Seeds; University of New Mexico.Specific aim #1 for the project is to determine what is responsible for the up-regulation of neuroserpin in the Alzheimer's disease brain. Specific aim #2 for the project is to use a sensitive high throughput assay screen for inhibitors of neuroserpin to a) screen commercially available libraries and selected chemical compounds, b) use medicinal chemistry to optimize and design new molecules based on the structures of identified hit candidate molecules (above) and crystal structure of neurserpin, c) confirmation of screening "hits", rule out false positives, do dose response curves and counter-screens to identify "leads", and d) test for "hit" interaction with neuroserpin, possible mechanism of action and potential toxicity in hippocampal neuronal cell cultures. |
| 65323 | Documentary ProjectIndependent video producer and author of books and articles on Alzheimer's disease, David Shenk, has obtained support from the MetLife Foundation for underwriting several short videos on Alzheimer's from the patient and care-giver perspective. Shenk and Metlife have asked Cure Alzheimer's Fund to serve as fiscal agent for the project with all editorial and production responsibility residing with Shenk. Cure Alzheimer's Fund receives funds from MetLife and disburses them by invoice upon request by Shenk. The estimated budget is $372,000 and the amount disbursed during 2011 was $65,323. |
| 2500 | AlzGene ProjectThe AlzGene database (www.alzgene.org) is a revolutionary resource for Alzheimer's researchers providing data and meta-analyses from hundreds of genetic association studies in an easy-to-use, searchable, web-based database. This site allows researchers to post their findings and comment on other findings. It aggregates huge amounts of information that will help in the search for the genetic makeup of Alzheimer's. Currently, the database has more than 1,000 studies. The site also contains a continuously updated list displaying the genes most strongly associated with AD (on the website see "Top AlzGene Results"). Scientists interested in a particular gene can search for it in AlzGene to see what previous studies have reported, receiving a wealth of information in a very short amount of time. 2011 expenses were for web maintenance. |
| 100000 | Mechanisms of Retinoid X Receptor-mediated Abeta Clearance in Ad; Gary Landreth; Case Western Reserve University; This application represents collaboration between the laboratories of Dr. David Holtzman, Rudolph Tanzi and Gary Landreth that is focused on investigating the mechanisms through which RXRs promote amyloid clearance from the brain. The Landreth lab will specifically determine if RXR agonist treatment of murine models of AD provokes the conversion of microglia from a proinflammatory state into alternative M2 states that are associated with tissue repair and induction of phagocytic functions, all contributing to evidence that the drugbexarotene, originally developed to treat a rare form of lymphoma, is effective against Alzheimer's disease. |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Other Program Service Exp | 1417823 | TotalOfOtherProgramServiceExp |
| Total Program Service Expense | 2525927 | TotalProgramServiceExpense |
| Described In501 C3 | 1 | DescribedIn501C3 |
| Schedule B Required | 1 | ScheduleBRequired |
| Political Activities | 0 | PoliticalActivities |
| Lobbying Activities | 1 | LobbyingActivities |
| Donor Advised Funds | 0 | DonorAdvisedFunds |
| Conservation Easements | 0 | ConservationEasements |
| Collections Of Art | 0 | CollectionsOfArt |
| Credit Counseling | 0 | CreditCounseling |
| Term Or Permanent Endowments | 0 | TermOrPermanentEndowments |
| Report Land Bldg Equip | 1 | ReportLandBldgEquip |
| Report Invest Oth Securities | 0 | ReportInvestOthSecurities |
| Report Prog Rel Invest | 0 | ReportProgRelInvest |
| Report Other Assets | 0 | ReportOtherAssets |
| Report Other Liabilities | 1 | ReportOtherLiabilities |
| Report Fin48 Footnote | 1 | ReportFin48Footnote |
| Independent Audit Financial Stmt | 1 | IndependentAuditFinancialStmt |
| Consolidated Audit Financial Stmt | 0 | ConsolidatedAuditFinancialStmt |
| School | 0 | School |
| Foreign Office | 0 | ForeignOffice |
| Foreign Activities | 0 | ForeignActivities |
| More Than5000 K To Organizations | 0 | MoreThan5000KToOrganizations |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividuals |
| Professional Fundraising | 0 | ProfessionalFundraising |
| Fundraising Activities | 0 | FundraisingActivities |
| Gaming | 0 | Gaming |
| Hospital | 0 | Hospital |
| Grants To Organizations | 1 | GrantsToOrganizations |
| Grants To Individuals | 0 | GrantsToIndividuals |
| Schedule J Required | 1 | ScheduleJRequired |
| Tax Exempt Bonds | 0 | TaxExemptBonds |
| Excess Benefit Transaction | 0 | ExcessBenefitTransaction |
| Prior Excess Benefit Transaction | 0 | PriorExcessBenefitTransaction |
| Loan To Officer Or DQP | 0 | LoanToOfficerOrDQP |
| Grant To Related Person | 0 | GrantToRelatedPerson |
| Bsnss Rltnshp With Organization | 0 | BsnssRltnshpWithOrganization |
| Bsnss Rltnshp Thru Family Member | 0 | BsnssRltnshpThruFamilyMember |
| Officer Entity With Bsnss Rltnshp | 0 | OfficerEntityWithBsnssRltnshp |
| Deductible Non Cash Contributions | 1 | DeductibleNonCashContributions |
| Deductible Contributions Of Art | 0 | DeductibleContributionsOfArt |
| Terminated | 0 | Terminated |
| Partial Liquidation | 0 | PartialLiquidation |
| Disregarded Entity | 0 | DisregardedEntity |
| Related Entity | 0 | RelatedEntity |
| Related Org Controlled Entity | 0 | RelatedOrgControlledEntity |
| Transaction Related Entity | 0 | TransactionRelatedEntity |
| Transfers To Exempt Non Chrtbl Org | 0 | TransfersToExemptNonChrtblOrg |
| Activities Conducted Partnership | 0 | ActivitiesConductedPartnership |
| Schedule O Required | 1 | ScheduleORequired |
| Number Forms Transmitted With1096 | 0 | NumberFormsTransmittedWith1096 |
| Number W2 G Included | 0 | NumberW2GIncluded |
| Number Of Employees | 6 | NumberOfEmployees |
| Employment Tax Returns Filed | 1 | EmploymentTaxReturnsFiled |
| Unrelated Business Income | 0 | UnrelatedBusinessIncome |
| Foreign Financial Account | 0 | ForeignFinancialAccount |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTrans |
| Taxable Party Notification | 0 | TaxablePartyNotification |
| Non Deductible Contributions | 0 | NonDeductibleContributions |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributions |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOf |
| Indoor Tanning Services | 0 | IndoorTanningServices |
| Info In Schedule O Part VI | X | InfoInScheduleOPartVI |
| Nbr Voting Governing Body Members | 6 | NbrVotingGoverningBodyMembers |
| Number Independent Voting Members | 5 | NumberIndependentVotingMembers |
| Family Or Business Relationship | 1 | FamilyOrBusinessRelationship |
| Delegation Of Management Duties | 0 | DelegationOfManagementDuties |
| Changes To Organizing Docs | 0 | ChangesToOrganizingDocs |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuse |
| Members Or Stockholders | 0 | MembersOrStockholders |
| Election Of Board Members | 0 | ElectionOfBoardMembers |
| Decisions Subject To Approval | 0 | DecisionsSubjectToApproval |
| Minutes Of Governing Body | 1 | MinutesOfGoverningBody |
| Minutes Of Committees | 1 | MinutesOfCommittees |
| Officer Mailing Address | 1 | OfficerMailingAddress |
| Local Chapters | 0 | LocalChapters |
| Form990 Provided To Governing Body | 1 | Form990ProvidedToGoverningBody |
| Conflict Of Interest Policy | 1 | ConflictOfInterestPolicy |
| Annual Disclosure Covered Persons | 1 | AnnualDisclosureCoveredPersons |
| Regular Monitoring Enforcement | 1 | RegularMonitoringEnforcement |
| Whistleblower Policy | 1 | WhistleblowerPolicy |
| Document Retention Policy | 1 | DocumentRetentionPolicy |
| Compensation Process CEO | 1 | CompensationProcessCEO |
| Compensation Process Other | 0 | CompensationProcessOther |
| Investment In Joint Venture | 0 | InvestmentInJointVenture |
| States Where Copy Of Return Is Filed | MA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | AL | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | AK | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | AS | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | AZ | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | AR | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | CA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | CO | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | CT | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | DE | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | DC | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | FM | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | FL | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | GA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | GU | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | HI | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | ID | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | IL | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | IN | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | IA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | KS | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | KY | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | LA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | ME | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MH | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MD | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MI | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MN | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MS | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MO | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MT | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NE | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NV | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NH | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NJ | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NM | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NY | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NC | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | ND | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MP | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | OH | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | OK | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | OR | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | PW | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | PA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | PR | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | RI | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | SC | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | SD | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | TN | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | TX | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | UT | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | VT | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | VI | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | VA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | WA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | WV | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | WI | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | WY | StatesWhereCopyOfReturnIsFiled |
| Own Website | X | OwnWebsite |
| Upon Request | X | UponRequest |
The Books Are In Care Of TheBooksAreInCareOf
Name Business NameBusiness
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Timour W Armour | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Telephone Number | 7812373800 | TelephoneNumber |
Address US AddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 34 Washington Street Suite 200 | AddressLine1 |
| City | Wellesley Hills | City |
| State | MA | State |
| ZIP Code | 02481 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part VII | X | InfoInScheduleOPartVII |
Form990 Part VII Section A Form990PartVIISectionA (9 entries)
| TitleTitle | Average Hours Per WeekAverageHoursPerWeek | Individual Trustee Or DirectorIndividualTrusteeOrDirector | Reportable Comp From OrganizationReportableCompFromOrganization | Reportable Comp From Related OrgsReportableCompFromRelatedOrgs | Other CompensationOtherCompensation | OfficerOfficer |
|---|---|---|---|---|---|---|
| Jeffrey Morby | ||||||
| Chairman of the Board | 2.00 | X | 0 | 0 | 0 | |
| Jacqueline Morby | ||||||
| Director | 5.00 | X | 0 | 0 | 0 | |
| Henry McCance | ||||||
| Director | 1.00 | X | 0 | 0 | 0 | |
| Phyllis Rappaport | ||||||
| Director | 1.00 | X | 0 | 0 | 0 | |
| John S Lazo PhD | ||||||
| Director | 1.00 | X | 0 | 0 | 0 | |
| Timothy W Armour | ||||||
| President | 40.00 | 194257 | 0 | 0 | X | |
| Katherine F Cutler | ||||||
| Secretary | 30.00 | 12570 | 0 | 0 | X | |
| Michael FCurren | ||||||
| Secretary and Sr. Vice President | 40.00 | 88846 | 0 | 0 | X | |
| Sally G Rosenfield | ||||||
| Vice President | 40.00 | 83462 | 0 | 0 | X | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | 379135 | TotalReportableCompFromOrg |
| Total Reportable Comp Frm Rltd Orgs | 0 | TotalReportableCompFrmRltdOrgs |
| Total Other Compensation | 0 | TotalOtherCompensation |
| Number Individuals GT100 K | 1 | NumberIndividualsGT100K |
| Formers Listed | 0 | FormersListed |
| Total Comp GT150 K | 1 | TotalCompGT150K |
| Compensation From Other Sources | 0 | CompensationFromOtherSources |
| Number Of Contractors GT100 K | 0 | NumberOfContractorsGT100K |
| All Other Contributions | 4682190 | AllOtherContributions |
| Noncash Contributions | 626188 | NoncashContributions |
| Total Contributions | 4682190 | TotalContributions |
Investment Income InvestmentIncome
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 1132 | TotalRevenueColumn |
| Exclusion | $1,132 | ExclusionAmount |
Gross Amount Sales Assets GrossAmountSalesAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | 623688 | Securities |
Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | 619736 | Securities |
Gain Or Loss GainOrLoss
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | 3952 | Securities |
Net Gain Or Loss Investments NetGainOrLossInvestments
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 3952 | TotalRevenueColumn |
| Related Or Exempt Function Income | 3952 | RelatedOrExemptFunctionIncome |
Total Revenue TotalRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 4687274 | TotalRevenueColumn |
| Related Or Exempt Function Income | 3952 | RelatedOrExemptFunctionIncome |
| Unrelated Business Revenue | 0 | UnrelatedBusinessRevenue |
| Exclusion | $1,132 | ExclusionAmount |
Grants To Domestic Orgs GrantsToDomesticOrgs
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 2052500 | Total |
| Program Services | 2052500 | ProgramServices |
Comp Current Officers Directors CompCurrentOfficersDirectors
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 398173 | Total |
| Program Services | 135701 | ProgramServices |
| Management And General | 138241 | ManagementAndGeneral |
| Fundraising | 124231 | Fundraising |
Payroll Taxes PayrollTaxes
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 47758 | Total |
| Program Services | 13947 | ProgramServices |
| Management And General | 19306 | ManagementAndGeneral |
| Fundraising | 14505 | Fundraising |
Fees For Services Legal FeesForServicesLegal
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 2768 | Total |
| Management And General | 2768 | ManagementAndGeneral |
Fees For Services Accounting FeesForServicesAccounting
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 40609 | Total |
| Management And General | 40609 | ManagementAndGeneral |
Fees For Services Other FeesForServicesOther
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 10795 | Total |
| Management And General | 1670 | ManagementAndGeneral |
| Fundraising | 9125 | Fundraising |
Advertising Advertising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 2806 | Total |
| Fundraising | 2806 | Fundraising |
Office Expenses OfficeExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 5836 | Total |
| Management And General | 5836 | ManagementAndGeneral |
Occupancy Occupancy
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 34707 | Total |
| Management And General | 34707 | ManagementAndGeneral |
Travel Travel
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 30931 | Total |
| Program Services | 16050 | ProgramServices |
| Management And General | 13137 | ManagementAndGeneral |
| Fundraising | 1744 | Fundraising |
Conferences Meetings ConferencesMeetings
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 6937 | Total |
| Program Services | 886 | ProgramServices |
| Management And General | 3222 | ManagementAndGeneral |
| Fundraising | 2829 | Fundraising |
Depreciation Depletion DepreciationDepletion
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 8995 | Total |
| Management And General | 8995 | ManagementAndGeneral |
Insurance Insurance
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 1872 | Total |
| Management And General | 1872 | ManagementAndGeneral |
Other Expenses OtherExpenses (4 entries)
| DescriptionDescription | TotalTotal | Program ServicesProgramServices | FundraisingFundraising |
|---|---|---|---|
| Information and awarene | 187635 | 187635 | |
| Documentaries | 65323 | 65323 | |
| Public relations | 49931 | 49931 | |
| Government relations | 36000 | 36000 |
All Other Expenses AllOtherExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 139694 | Total |
| Program Services | 17885 | ProgramServices |
| Management And General | 59929 | ManagementAndGeneral |
| Fundraising | 61880 | Fundraising |
Total Functional Expenses TotalFunctionalExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 3123270 | Total |
| Program Services | 2525927 | ProgramServices |
| Management And General | 330292 | ManagementAndGeneral |
| Fundraising | 267051 | Fundraising |
Cash Non Interest Bearing CashNonInterestBearing
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 654165 | BOY |
| EOY | 1328315 | EOY |
Savings And Temp Cash Investments SavingsAndTempCashInvestments
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 2343857 | BOY |
| EOY | 3029460 | EOY |
Pledges And Grants Receivable PledgesAndGrantsReceivable
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 15267 | BOY |
Accounts Receivable AccountsReceivable
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 219843 | BOY |
| EOY | 192993 | EOY |
Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 3810 | BOY |
| EOY | 1762 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Buildings Equipment Basis | 50525 | LandBuildingsEquipmentBasis |
| Land Bldg Equipment Accum Deprec | 24005 | LandBldgEquipmentAccumDeprec |
Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 13813 | BOY |
| EOY | 26520 | EOY |
Intangible Assets IntangibleAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 386 | BOY |
| EOY | 308 | EOY |
Other Assets Total OtherAssetsTotal
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 21998 | BOY |
| EOY | 22013 | EOY |
Total Assets TotalAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 3273139 | BOY |
| EOY | 4601371 | EOY |
Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 307585 | BOY |
| EOY | 31531 | EOY |
Other Liabilities OtherLiabilities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 11351 | BOY |
| EOY | 19372 | EOY |
Total Liabilities TotalLiabilities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 318936 | BOY |
| EOY | 50903 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Do Not Follow SFAS117 | X | DoNotFollowSFAS117 |
Cap Stck Trst Prin Current Funds CapStckTrstPrinCurrentFunds
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 0 | BOY |
| EOY | 0 | EOY |
Paid In Cap Srpls Land Bldg Eqp Fund PaidInCapSrplsLandBldgEqpFund
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 0 | BOY |
| EOY | 0 | EOY |
Retained Earnings Endowment Etc RetainedEarningsEndowmentEtc
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 0 | BOY |
| EOY | 1596265 | EOY |
Total Net Assets Fund Balances TotalNetAssetsFundBalances
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 2954203 | BOY |
| EOY | 4550468 | EOY |
Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 3273139 | BOY |
| EOY | 4601371 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | X | InfoInScheduleOPartXI |
| Reconcilation Revenue Expenses | 1564004 | ReconcilationRevenueExpenses |
| Reconcilation Other Changes | 32261 | ReconcilationOtherChanges |
| Method Of Accounting Accrual | X | MethodOfAccountingAccrual |
| Accountant Compile Or Review | 0 | AccountantCompileOrReview |
| FS Audited | 1 | FSAudited |
| Audit Committee | 1 | AuditCommittee |
| Financial Statement Separate | X | FinancialStatementSeparate |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequired |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Publicly Supported Org170b1 Avi | X | PubliclySupportedOrg170b1Avi |
Gifts Grants Contrib Received170 GiftsGrantsContribReceived170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 3560203 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 3042089 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 3339366 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 4039719 | CurrentTaxYearMinus1Year |
| Current Tax Year | 4763246 | CurrentTaxYear |
| Total | 18744623 | Total |
Total170 Total170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 3560203 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 3042089 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 3339366 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 4039719 | CurrentTaxYearMinus1Year |
| Current Tax Year | 4763246 | CurrentTaxYear |
| Total | 18744623 | Total |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Amounts Subst Contributors Total | 7470070 | AmountsSubstContributorsTotal |
| Public Support Total170 | 11274553 | PublicSupportTotal170 |
Gross Investment Income170 GrossInvestmentIncome170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 97016 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 74626 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 20020 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | -5755 | CurrentTaxYearMinus1Year |
| Current Tax Year | 5084 | CurrentTaxYear |
| Total | 190991 | Total |
Other Income170 OtherIncome170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus2 Years | -498 | CurrentTaxYearMinus2Years |
| Total | -498 | Total |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | 18935116 | TotalSupport |
| Public Support Pertcentage170 | 0.59540 | PublicSupportPertcentage170 |
| Public Support Pertcent Prior Year | 0.58230 | PublicSupportPertcentPriorYear |
| Thirty Three Percnt Tests CY170 | X | ThirtyThreePercntTestsCY170 |
Schedule B IRS990ScheduleB
Contributor Info ContributorInfo
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor Number | RESTRICTED | ContributorNumber |
Contributor Name Business ContributorNameBusiness
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor Address US ContributorAddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Aggregate Contributions | RESTRICTED | AggregateContributions |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Volunteers | 0 | Volunteers |
| Paid Staff Or Management | 0 | PaidStaffOrManagement |
| Media Advertisements | 0 | MediaAdvertisements |
| Mailings Members | 0 | MailingsMembers |
| Publications Or Broadcast | 0 | PublicationsOrBroadcast |
| Grants Other Organizations | 0 | GrantsOtherOrganizations |
| Direct Contact Legislators | 1 | DirectContactLegislators |
| Direct Contact Legislators | $41,032 | DirectContactLegislatorsAmount |
| Rallies Demonstrations | 0 | RalliesDemonstrations |
| Other Activities | 0 | OtherActivities |
| Total Lobbying Expenditures IIB | 41032 | TotalLobbyingExpendituresIIB |
| Not Described In501c3 | 0 | NotDescribedIn501c3 |
Form990 Schedule C Part IV Form990ScheduleCPartIV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | Explanation of Other Lobbying Activities: | Identifier |
| Return Reference | Part II-B, Line 1i: | ReturnReference |
| Explanation | A registered lobbyist contacted various Congressional legislators for the purpose of encouraging increased funding of Alzheimer's disease research. | Explanation |
Schedule D IRS990ScheduleD
Equipment Equipment
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 24377 | OtherCostOrOtherBasis |
| Depreciation | 11787 | Depreciation |
| Book Value | 12590 | BookValue |
Other Land Buildings OtherLandBuildings
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 26148 | OtherCostOrOtherBasis |
| Depreciation | 12218 | Depreciation |
| Book Value | 13930 | BookValue |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Book Value Land Buildings | 26520 | TotalOfBookValueLandBuildings |
Other Liabilities OtherLiabilities (2 entries)
| DescriptionDescription | AmountAmount |
|---|---|
| Accrued payroll | $18,507 |
| 403b employee contributions | $865 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Amounts | 19372 | TotalOfAmounts |
| Total Revenue | 4687274 | TotalRevenue |
| Total Expenses | 3123270 | TotalExpenses |
| Excess Or Deficit For Year | 1564004 | ExcessOrDeficitForYear |
| Donated Services And Facilities | 32575 | DonatedServicesAndFacilities |
| Other | -$314 | OtherAmount |
| Total Adjustments | 32261 | TotalAdjustments |
| Excess Or Deficit Per FS | 1596265 | ExcessOrDeficitPerFS |
| Tot Revenue Etc Audited Fincl Stmt | 4428125 | TotRevenueEtcAuditedFinclStmt |
| Net Unrealized Gains Investments | -314 | NetUnrealizedGainsInvestments |
| Donated Srvc And Use Of Facilities | 32575 | DonatedSrvcAndUseOfFacilities |
| Other Revenues | 80823 | OtherRevenues |
| Revenue Not Rptd F990 | 113084 | RevenueNotRptdF990 |
| Revenue Subtotal | 4315041 | RevenueSubtotal |
| Other Revenues Not Included | 372233 | OtherRevenuesNotIncluded |
| Revenue Not Rptd On Fin Stmt | 372233 | RevenueNotRptdOnFinStmt |
| Total Revenue Per Form990 | 4687274 | TotalRevenuePerForm990 |
| Tot Expenses Etc Audited Fincl Stmt | 3123270 | TotExpensesEtcAuditedFinclStmt |
| Donated Services Use Of Facilities | 32575 | DonatedServicesUseOfFacilities |
| Expenses Not Rptd F990 | 32575 | ExpensesNotRptdF990 |
| Expenses Subtotal | 3090695 | ExpensesSubtotal |
| Other Expenses Not Included | 32575 | OtherExpensesNotIncluded |
| Expenses Not Rptd On Fin Stmt | 32575 | ExpensesNotRptdOnFinStmt |
| Total Expenses Per Form990 | 3123270 | TotalExpensesPerForm990 |
Form990 Schedule D Part XIV Form990ScheduleDPartXIV (2 entries)
| IdentifierIdentifier | Return ReferenceReturnReference | ExplanationExplanation |
|---|---|---|
| Description of Uncertain Tax Positions Under FIN 48: | Part X: | Part X, Line 2: Income Taxes - CAF was determined to be exempt from federal income tax under provisions of Section 501(c)(3) of the Internal Revenue Code of 1986 (IRC) and has been classified as an organization that is not a private foundation as defined in Section 509(a)(3) of the IRC. Accordingly, no provisions for federal or state income taxes are required. CAF is required to recognize the financial statement impact of a tax position when it is more likely than not that the position will be sustained upon examination. Any interest and penalties recognized associated with a tax position would be classified as current in CAF's financial statements. Currently, the tax years ended December 31, 2007, 2008, and 2009 are open and subject to examination by the Internal Revenue Service and the Massachusetts Department of Revenue. However, CAF is not currently under audit nor has CAF been contacted by any of these jurisdictions. Based on the evaluation of CAF's tax positions, management believes all positions taken would be upheld under an examination. Therefore, no provision for the effects of uncertain tax positions has been recorded for the year ended December 31, 2011. |
| Part XI, Line 8 - Other Adjustments: | Unrealized gains (losses) on investments -314. |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Records Maintained | 0 | RecordsMaintained |
Recipient Table RecipientTable (15 entries)
| Address Line1AddressUS/AddressLine1 | CityAddressUS/City | StateAddressUS/State | ZIP CodeAddressUS/ZIPCode | IRC SectionIRCSection | Amount Of Cash GrantAmountOfCashGrant | Purpose Of GrantPurposeOfGrant |
|---|---|---|---|---|---|---|
| Massachusetts General Hospital MGH Aging and Research Unit | ||||||
| 114 16th Street | Charlestown | MA | 02129 | 501c3 | 600000 | Continuation of Alzheimer's Genome Project |
| Massachusetts General Hospital MGH Aging and Research Unit | ||||||
| 114 16th Street | Charlestown | MA | 02129 | 501c3 | 150000 | Optimization of Novel ACAT Inhibitors |
| Massachusetts General Hospital MGH Aging and Research Unit | ||||||
| 114 16th Street | Charlestown | MA | 02129 | 501c3 | 100000 | Alzheimer's Disease Models Based on Human Neuronal Progenitor Cells |
| Massachusetts General Hospital MGH Aging and Research Unit | ||||||
| 114 16th Street | Charlestown | MA | 02129 | 501c3 | 100000 | Exploring Adult Neurogenesis as a Therapeutic Target for Alzheimer's Disease |
| Washington University at St Louis | ||||||
| 660 S Euclid Avenue | St Louis | MO | 63110 | 501c3 | 100000 | Effect of Bexaratene on Abeta in Alzheimer's disease |
| Case Western Reserve University | ||||||
| 10900 Euclid Avenue | Cleveland | OH | 441067043 | 501c3 | 100000 | Mechanisms of Retinoid X Receptor-mediated Abeta Clearance in AD |
| University of California Los Angeles | ||||||
| 405 Hilgard Avenue | Los Angeles | CA | 90095 | 501c3 | 100000 | Molecular Tweezers: Novel Inhibitors of amyloidogenic proteins and promising drug |
| University of California San Diego | ||||||
| 9500 Gilman Drive | La Jolla | CA | 92093 | 501c3 | 150000 | Novel Soluble Gamma-Secretase Modulators for the Treatment of Alzheimer's |
| The University of Chicago School of Medicine Chicago | ||||||
| 5841 South Maryland Avenue | Chicago | IL | 60637 | 501c3 | 100000 | Modulation of Abeta Deposition by Cell-Specific Mechanisms |
| The Rockefeller University | ||||||
| 1230 York Avenue | New York | NY | 10065 | 501c3 | 100000 | Selective Cell Vulnerability in Alzheimer's disease |
| University of Virginia | ||||||
| PO Box 800793 | Charlottesville | VA | 22908 | 501c3 | 100000 | Structuraland Functional Analysis of Novel Abeta and Tau Oligomers Using Conformation specific |
| University of California Irvine Medical Center | ||||||
| 101 The City Drive | Orange | CA | 92868 | 501c3 | 100000 | Cellular and animal models of amyloid pathology in early Alzheimer's disease |
| University of New Mexico | ||||||
| 1 University of New Mexico | Albuquerque | NM | 87131 | 501c3 | 50000 | Understanding the up-regulation of Neurosperpin in AD diseased brain |
| Tufts University School of Medicine | ||||||
| 145 Harrison Avenue | Boston | MA | 02111 | 501c3 | 100000 | Role of ADAM10 in the pathogenesis of AD after head trauma |
| Boston University | ||||||
| 700 Albany Street | Boston | MA | 02118 | 501c3 | 100000 | Metallomic Mapping of the Aging Brain in the Trg2576 Mouse Model |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Nbr Of501 C3 And Govt Grants | 15 | TotalNbrOf501C3AndGovtGrants |
| Total Nbr Of Other Organizations | 15 | TotalNbrOfOtherOrganizations |
Form990 Schedule I Part IV Form990ScheduleIPartIV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | Schedule I,Part I, Line 2 | Identifier |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantiation Required | 1 | SubstantiationRequired |
| Compensation Committee | X | CompensationCommittee |
| Severance Payment | 0 | SeverancePayment |
| Supplemental Nonqual Retire Plan | 0 | SupplementalNonqualRetirePlan |
| Equity Based Comp Arrangement | 0 | EquityBasedCompArrangement |
| Comp Based On Revenue Of Filing Org | 0 | CompBasedOnRevenueOfFilingOrg |
| Comp Based On Revenue Related Orgs | 0 | CompBasedOnRevenueRelatedOrgs |
| Comp Based Net Earnings Filing Org | 0 | CompBasedNetEarningsFilingOrg |
| Comp Based Net Earnings Relate Orgs | 0 | CompBasedNetEarningsRelateOrgs |
| Any Non Fixed Payments | 0 | AnyNonFixedPayments |
| Initial Contract Exception | 0 | InitialContractException |
Form990 Schedule J Part II Form990ScheduleJPartII
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Person | Timothy W Armour | NamePerson |
| Base Compensation Filing Org | 184257 | BaseCompensationFilingOrg |
| Comp Based On Related Orgs | 0 | CompBasedOnRelatedOrgs |
| Bonus Filing Org | 10000 | BonusFilingOrg |
| Bonus Related Orgs | 0 | BonusRelatedOrgs |
| Other Compensation Filing Org | 0 | OtherCompensationFilingOrg |
| Other Compensation Related Orgs | 0 | OtherCompensationRelatedOrgs |
| Deferred Comp Filing Org | 0 | DeferredCompFilingOrg |
| Deferred Comp Related Orgs | 0 | DeferredCompRelatedOrgs |
| Nontaxable Benefits Filing Org | 0 | NontaxableBenefitsFilingOrg |
| Nontaxable Benefits Related Orgs | 0 | NontaxableBenefitsRelatedOrgs |
| Total Compensation Filing Org | 194257 | TotalCompensationFilingOrg |
| Total Compensation Related Orgs | 0 | TotalCompensationRelatedOrgs |
| Comp Report Prior990 Filing Org | 0 | CompReportPrior990FilingOrg |
| Comp Report Prior990 Related Orgs | 0 | CompReportPrior990RelatedOrgs |
Form990 Schedule J Part III Form990ScheduleJPartIII (2 entries)
| Return ReferenceReturnReference | ExplanationExplanation |
|---|---|
| Part I, Line 1b | None of the above fringe benefits are paid. |
| Part I, Line 3 | A compensation committee reviews all compensation annually. |
Schedule M IRS990ScheduleM
Securities Publicly Traded SecuritiesPubliclyTraded
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | X | NonCashCheckbox |
| Number Of Contributions | 11 | NumberOfContributions |
| Noncash Contribs Rptd F990 | 623086 | NoncashContribsRptdF990 |
| Method Of Determining Revenues | average high and low | MethodOfDeterminingRevenues |
Other Non Cash Contributions Table OtherNonCashContributionsTable
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | X | NonCashCheckbox |
| Description | Services | Description |
| Number Of Contributions | 1 | NumberOfContributions |
| Noncash Contribs Rptd F990 | 32575 | NoncashContribsRptdF990 |
| Method Of Determining Revenues | Invoice amount | MethodOfDeterminingRevenues |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | 0 | AnyPropertyThatMustBeHeld |
| Review Process Unusual NC Gifts | 0 | ReviewProcessUnusualNCGifts |
| Third Parties Used | 0 | ThirdPartiesUsed |
Schedule O IRS990ScheduleO
General Explanation GeneralExplanation (8 entries)
| Return ReferenceReturnReference | ExplanationExplanation | IdentifierIdentifier |
|---|---|---|
| Form 990, Part VI, Section A, line 2 | Jeffrey Morby and Jacqueline Morby are both directors and marriage partners. | |
| Form 990, Part VI, Section B, line 11 | The President reviews the Form 990 prepared by the organization's controller before providing copies to the directors, and if necessary, will consult with legal counsel. | |
| Form 990, Part VI, Section B, line 12c | The President regularly and consistently monitors compliance with conflicts of interest by requesting that all officers, directors, and founders sign the annual statement disclosing all interests that might conflict with any interest of the organization. | |
| Form 990, Part VI, Section B, line 15a | Comparability data are submitted annually to executive committee for compensation approval for the President and all other employees. | |
| Form 990, Part VI, Section C, line 18 | The governing documents, conflict of interest policy and financial statements are made available on the organization's website and upon request. | |
| Form 990, Part VI, Section C, line 19 | The organization's governing documents are available upon request. | |
| PART 7, SECTION A | Henry McCance, 2300 North Scenic Highway, Lake Wales, FL 33898 Jeffrey and Jacqueline Morby, 18 South Island Drive, Key Largo, FL 33037 | |
| Form 990, Part XI, line 5: | Net unrealized losses on investments: -314. Donated services 32,575. Total to Form 990, Part XI, Line 5: 32,261. | Changes in Net Assets or Fund Balances: |
Comments